Back to Search
Start Over
A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
- Source :
- eLife. 11
- Publication Year :
- 2022
- Publisher :
- eLife Sciences Publications, Ltd, 2022.
-
Abstract
- Placental malaria (PM) is a deadly syndrome most frequent and severe in first pregnancies. PM results from accumulation of Plasmodium falciparum-infected erythrocytes (IE) that express the surface antigen VAR2CSA and bind to chondroitin sulfate A (CSA) in the placenta. Women become PM-resistant over successive pregnancies as they develop anti-adhesion and anti-VAR2CSA antibodies, supporting VAR2CSA as the leading PM-vaccine candidate. However, the first VAR2CSA subunit vaccines failed to induce broadly neutralizing antibody and it is known that naturally acquired antibodies target both variant-specific and conserved epitopes. It is crucial to determine whether effective vaccines will require incorporation of many or only a single VAR2CSA variants. Here, IgG from multigravidae was sequentially purified on five full-length VAR2CSA ectodomain variants, thereby depleting IgG reactivity to each. The five VAR2CSA variants purified ~0.7% of total IgG and yielded both strain-transcending and strain-specific reactivity to VAR2CSA and IE-surface antigen. In two independent antibody purification/depletion experiments with permutated order of VAR2CSA variants, IgG purified on the first VAR2CSA antigen displayed broad cross-reactivity to both recombinant and native VAR2CSA variants, and inhibited binding of all isolates to CSA. IgG remaining after depletion on all variants showed significantly reduced binding-inhibition activity compared to initial total IgG. These findings demonstrate that a single VAR2CSA ectodomain variant displays conserved epitopes that are targeted by neutralizing (or binding-inhibitory) antibodies shared by multiple parasite strains, including maternal isolates. This suggests that a broadly effective PM-vaccine can be achieved with a limited number of VAR2CSA variants.
- Subjects :
- Erythrocytes
General Immunology and Microbiology
Placenta
General Neuroscience
Chondroitin Sulfates
Plasmodium falciparum
Antibodies, Protozoan
Antigens, Protozoan
General Medicine
General Biochemistry, Genetics and Molecular Biology
Malaria
Epitopes
Pregnancy
Immunoglobulin G
Antigens, Surface
Malaria Vaccines
embryonic structures
parasitic diseases
Humans
Female
Malaria, Falciparum
Broadly Neutralizing Antibodies
Subjects
Details
- ISSN :
- 2050084X
- Volume :
- 11
- Database :
- OpenAIRE
- Journal :
- eLife
- Accession number :
- edsair.doi.dedup.....ad5742510981a24f60be312e523e798b
- Full Text :
- https://doi.org/10.7554/elife.76264